Skip to main content
SpringerLink
Log in

Medikamente zur Behandlung von Abhängigkeit und Entzugssyndromen

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

  • 5020 Accesses

Zusammenfassung

In diesem Kapitel werden die Suchtmittel mit ihren Substanzcharakteristika, Entzugssyndromen, Entwöhnungsmaßnahmen und ihrer Intoxikationssymptomatik bzw. -therapie im Hinblick auf die verschiedenen spezifischen klinischen Syndrome der Suchtkrankheiten behandelt (► 7.1.2, Tab. 7.1). Die Gliederung erfolgt nicht nach Medikamentengruppen, sondern nach Suchtmitteln.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anthenelli RM, Morris C, Ramey TS et al (2013) Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med 159(6):390–400

    Article  PubMed  Google Scholar 

  • Beck A, Heinz A (2013) Alcohol-related aggression - social and neurobiological factors. Dtsch Arztebl Int 110(42):711–715

    PubMed Central  PubMed  Google Scholar 

  • Brown RM, Kupchik YM, Kalivas PW (2013) The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy- JAMA Psychiatry 70(9): 895

    Google Scholar 

  • Butelman ER, Yuferov V, Kreek MJ (2012) κ-Opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci 35(10):587–796

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Foa EB, Yusko DA, McLean CP et al (2013) Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial. JAMA 310:488

    Google Scholar 

  • Grant JE, Odlaug BL, Chamberlain SR et al (2014) A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry 75(1):39–45

    Article  CAS  PubMed  Google Scholar 

  • Grosshans M, Lemenager T, Vollmert C et al (2013) Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 69(12):2021–2025

    Article  CAS  PubMed  Google Scholar 

  • Heinzerling KG1, Swanson AN, Hall TM et al (2014) Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use. Addiction. doi: 10.1111/add.12636 (Epub ahead of print)

    PubMed  Google Scholar 

  • Hohmann N, Mikus G, Czock D (2014) Wirkungen und Risiken neuartiger psychoaktiver Substanzen. Dt Ärztebl 9:139–147

    Google Scholar 

  • Kampman KM, Pettinati HM, Lynch KG et al (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend 133(1):94–99

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kishi T, Sevy S, Chekuri R, Correll CU (2013) Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials. Clin Psychiatry 74(7):e642–e654

    Article  Google Scholar 

  • Lange-Asschenfeldt C, Muller MJ, Szegedi A et al (2003) Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis. Eur Addict Res 9:1–7

    Article  PubMed  Google Scholar 

  • Levin FR, Mariani J, Brooks DJ et al (2013) A randomized double-blind, placebo controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction 108(6):1084–1094

    Article  PubMed Central  PubMed  Google Scholar 

  • Mann K, Fauth-Bühler M, Seiferth N, Heinz A; Expertengruppe Verhaltenssüchte der DGPPN (2013) Konzept der Verhaltenssüchte und Grenzen des Suchtbegriffs. Nerven arzt 84(5): 548–556

    Google Scholar 

  • Meier MH, Caspi A, Ambler A et al (2012) Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 109(40):E2657–E2664

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nowak D, Jörres RA, Rüther T (2014) E-cigarettes-prevention, pulmonary health, and addiction. Dtsch Arztebl Int 111(20):349–355

    PubMed Central  PubMed  Google Scholar 

  • Sigmon SC, Dunn KE, Saulsgiver K et al (2013) A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. JAMA Psychiatry 70(12):1347–1354

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Soyka M (2014) Nalmefene for the treatment of alcohol dependence: a current update. Int J Neuropsychopharmacol 17(4):675–684

    Article  CAS  PubMed  Google Scholar 

  • Stapleton J, West R, Hajek P et al (2013) Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction 108(12):2193–2201

    Article  PubMed  Google Scholar 

  • Tiihonen J, Krupitsky E, Verbitskaya E et al (2012) Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry 169(5):531–536

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mainz

    O. Benkert

Authors
  1. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O. (2015). Medikamente zur Behandlung von Abhängigkeit und Entzugssyndromen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54769-0_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54768-3

  • Online ISBN: 978-3-642-54769-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation